Document Detail


Comparative vaccine-specific and other injectable-specific risks of injection-site sarcomas in cats.
MedLine Citation:
PMID:  22916856     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Objective-To compare associations between vaccine types and other injectable drugs with development of injection-site sarcomas in cats. Design-Case-control study. Animals-181 cats with soft tissue sarcomas (cases), 96 cats with tumors at non-vaccine regions (control group I), and 159 cats with basal cell tumors (control group II). Procedures-Subjects were prospectively obtained from a large pathology database. Demographic, sarcoma location, basal cell tumor, and vaccine and other injectable history data were documented by use of a questionnaire and used to define case, control, and exposure status. Three control groups were included: cats with sarcomas at non-vaccine sites, cats with basal cell tumors, and a combined group of cats with sarcomas at non-vaccine sites and cats with basal cell tumors. χ(2) tests, marginal homogeneity tests, and exact logistic regression were performed. Results-In the broad interscapular region, the frequency of administration of long-acting corticosteroid injections (dexamethasone, methylprednisolone, and triamcinolone) was significantly higher in cases than in controls. In the broad rear limb region, case cats were significantly less likely to have received recombinant vaccines than inactivated vaccines; ORs from logistic regression analyses equaled 0.1, with 95% confidence intervals ranging from 0 to 0.4 and 0 to 0.7, depending on control group and time period of exposure used. Conclusions and Clinical Relevance-This case-control study measuring temporal and spatial exposures efficiently detected associations between administrations of various types of vaccines (recombinant vs inactivated rabies) and other injectable products (ie, long-acting corticosteroids) with sarcoma development without the need to directly measure incidence. These findings nevertheless also indicated that no vaccines were risk free. The study is informative in allowing practitioners to weigh the relative merits and risks of commonly used pharmaceutical products.
Authors:
Anup Srivastav; Philip H Kass; Lawrence D McGill; Thomas B Farver; Michael S Kent
Related Documents :
16090406 - Direct experimental evidence for current-transfer mode operation of nested tungsten wir...
22545546 - Recombinant iss as a potential vaccine for avian colibacillosis.
22426376 - Immunogenicity of a multi-epitope dna vaccine against hantavirus.
22306376 - Design considerations for liposomal vaccines: influence of formulation parameters on an...
22094636 - A randomized trial to assess safety and immunogenicity of alternative formulations of a...
12944096 - Preventive and therapeutic approaches to viral agents of bioterrorism.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the American Veterinary Medical Association     Volume:  241     ISSN:  1943-569X     ISO Abbreviation:  J. Am. Vet. Med. Assoc.     Publication Date:  2012 Sep 
Date Detail:
Created Date:  2012-08-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7503067     Medline TA:  J Am Vet Med Assoc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  595-602     Citation Subset:  IM    
Affiliation:
Department of Population Health and Reproduction, School of Veterinary Medicine, University of California-Davis, Davis, CA 95616.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of cognitive learning, memory, psychomotor, immunologic, and retinal functions in healthy...
Next Document:  Use of fluoroscopically guided percutaneous antegrade urethral catheterization for the treatment of ...